Literature DB >> 8064789

Hypertension in children with neurofibromatosis.

R Virdis1, P Balestrazzi, M Zampolli, A Donadio, M Street, E Lorenzetti.   

Abstract

Hypertension in neurofibromatosis is mostly a consequence of a stenosis of the renal artery or is due to phaeochromocytoma. Riccardi pointed out primary hypertension in patients with several cervical neurofibromas in the absence of phaeochromocytoma and he noticed that the elevation of BP was often already present in children. Nine (15.8%) of 57 neurofibromatosis patients (age from 1.5 to 23 years) examined, presented BP levels above the 95th percentile on several occasions and three in particular had severe hypertension with compromised target organs. Two of them had a stenosis of the renal artery, in the third an organic origin of hypertension was not demonstrated, but there was an asymptomatic glioma of the hypothalamus. The other six children had a labile or borderline hypertension and two of them had, respectively, a glioma of the thalamus and of the optical chiasm. Elevation of the catecholamine metabolites or other causes of hypertension were not found in any of these patients. These preliminary data show a high incidence of hypertension in neurofibromatosis, primary or due to organic causes and overall they point out a possible correlation between hypertension and cerebral neoplasia.

Entities:  

Mesh:

Year:  1994        PMID: 8064789

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  4 in total

1.  Blood pressure and cardiovascular involvement in children with neurofibromatosis type1.

Authors:  Giuliana Lama; Luisa Graziano; Elvira Calabrese; Carolina Grassia; Pier Francesco Rambaldi; Fabrizio Cioce; Michele Adolfo Tedesco; Giovanni Di Salvo; Maria Esposito-Salsano
Journal:  Pediatr Nephrol       Date:  2004-02-26       Impact factor: 3.714

2.  Giant phaeochromocytoma presenting with an acute stroke: reappraising phaeochromocytoma surveillance for the neurofibromatosis type 1 phakomatosis.

Authors:  Yingshan Lee; Leon Yuan Rui Tan; Yong Howe Ho; Melvin Khee Shing Leow
Journal:  BMJ Case Rep       Date:  2017-11-03

3.  Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966.

Authors:  Christina Bergqvist; Amandine Servy; Laurence Valeyrie-Allanore; Salah Ferkal; Patrick Combemale; Pierre Wolkenstein
Journal:  Orphanet J Rare Dis       Date:  2020-02-03       Impact factor: 4.123

4.  Identification of NF1 Frameshift Variants in Two Chinese Families With Neurofibromatosis Type 1 and Early-Onset Hypertension.

Authors:  Yi-Ting Lu; Di Zhang; Xin-Chang Liu; Qiong-Yu Zhang; Xue-Qi Dong; Peng Fan; Yan Xiao; Xian-Liang Zhou
Journal:  Front Pediatr       Date:  2021-12-20       Impact factor: 3.418

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.